Hims & Hers Sees 25% Q4 Subscriber Surge, Details Expansion Strategy
Hims & Hers Health reported record Q4 2025 revenue growth year-over-year driven by a 25% subscriber increase and higher average order values. Executives unveiled plans to expand telehealth offerings, pursue strategic partnerships and diversify the product portfolio to improve margins.
1. Q4 2025 Financial Results
Hims & Hers Health posted record Q4 2025 revenue growth, driven by a 25% rise in active subscribers and a notable increase in average order values. The company achieved positive adjusted EBITDA for the first time, reflecting improved operational efficiency.
2. Strategic Initiatives
Management outlined plans to broaden its telehealth service lineup, including virtual mental health and dermatology. They also announced partnerships with leading pharmacy networks and brands to diversify offerings and target a 300 basis-point gross margin expansion in 2026.